“Percutaneous exposures of volunteers to polychromatic light (480-3400 nm) trigger systemic mechanism of the human myeloma cells growth delay without any effect on bortezomib cytotoxicity in vitro” (2019) Laser Therapy, 28(3), pp. 164–170. doi:10.5978/islsm.28_19-OR-12.